Ocular Therapeutix Inc.
(OCUL)
undefined
undefined%
At close: undefined
8.69
0.23%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -80.74M | -71.04M | -6.55M | -155.64M | -86.37M | -59.98M | -63.39M | -44.70M | -39.75M | -28.65M | -13.32M | -14.09M |
| Depreciation & Amortization | 2.98M | 2.11M | 2.42M | 2.77M | 2.53M | 2.29M | 1.63M | 881.00K | 754.00K | 547.00K | 404.00K | 404.00K |
| Stock-Based Compensation | 17.82M | 16.96M | 14.98M | 7.53M | 8.76M | 7.48M | 7.32M | 5.96M | 4.64M | 2.64M | 476.00K | 243.00K |
| Other Working Capital | -2.81M | 2.88M | 4.24M | 11.58M | 1.08M | 1.45M | 2.60M | 2.27M | 20.00K | 1.85M | 250.00K | 8.00K |
| Other Non-Cash Items | -2.90M | -8.99M | 4.63M | 4.41M | 3.68M | 397.00K | 408.00K | 371.00K | 166.00K | 2.47M | 46.00K | 86.00K |
| Deferred Income Tax | - | - | -78.12M | 86.19M | -4.30M | - | 9.00K | 1.42M | -58.00K | 332.00K | -14.00K | 49.00K |
| Change in Working Capital | -7.41M | 1.35M | -2.90M | 1.18M | -1.88M | 585.00K | 3.55M | 2.08M | 503.00K | 2.16M | -240.00K | 726.00K |
| Operating Cash Flow | -70.23M | -59.60M | -65.55M | -53.55M | -77.58M | -49.23M | -50.47M | -34.00M | -33.74M | -20.50M | -12.64M | -12.59M |
| Capital Expenditures | -6.09M | -3.71M | -1.19M | -841.00K | -2.24M | -1.89M | -8.25M | -1.92M | -1.78M | -1.26M | -387.00K | -203.00K |
| Acquisitions | - | - | - | - | - | - | 5.00K | 2.00K | 7.00K | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | -3.00M | -41.70M | -91.68M | -37.33M | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | 38.20M | 80.68M | 54.83M | - | - | 4.02M |
| Other Investing Acitivies | - | -3.71M | - | - | - | - | 114.00K | -1.50M | 60.00K | -37.33M | - | 4.02M |
| Investing Cash Flow | -6.09M | -3.71M | -1.19M | -841.00K | -2.24M | -1.89M | 27.07M | 35.57M | -38.57M | -38.59M | -387.00K | 3.81M |
| Debt Repayment | 56.35M | - | -445.00K | - | 37.27M | 6.38M | 2.40M | - | 397.00K | 12.60M | -1.82M | 3.51M |
| Common Stock Repurchased | - | - | 985.00K | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | -2.38M | 1.45M | 3.30M | 3.33M | 529.00K | 694.00K | 370.00K | -42.00K | -306.00K | -3.15M | 8.50M | 23.79M |
| Financial Cash Flow | 169.83M | 1.45M | 2.85M | 228.01M | 75.34M | 68.64M | 32.01M | 585.00K | 65.70M | 78.97M | 6.68M | 27.30M |
| Net Cash Flow | 93.51M | -61.86M | -63.89M | 173.62M | -4.47M | 17.52M | 8.60M | 2.15M | -6.61M | 19.89M | -6.35M | 18.52M |
| Free Cash Flow | -76.32M | -63.32M | -66.74M | -54.40M | -79.82M | -51.12M | -58.73M | -35.92M | -35.52M | -21.76M | -13.03M | -12.79M |